View web version

This week Valeant was criticized for failing to provide promised discounts on two heart drugs; GSK tapped Emma Walmsley as its new CEO; AstraZeneca, Johnson & Johnson, and Pfizer agreed to remove incentives for their sales teams to sell high volumes of antibiotics; and House lawmakers questioned Mylan CEO Heather Bresch over the drugmaker's dramatic price increases of the EpiPen. 

Got a news tip or a pitch for next week's morning roundup? Email

The Week's Top Stories
Five things for pharma marketers to know: Friday, September 23, 2016
Alexion uses superheroes, social media to raise rare-disease awareness
McCann Health forms new global consultancy
The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study
Campaign seeks to educate doctors about when to prescribe opioids
Q&A: Cardiogram's Ballinger on using the Apple Watch to track heart rate
WebMD CEO departs, replaced by president
Commentaries from the Industry
Ogilvy's Michael Johnston on Using the Familiar in Diabetes Ads
By Michael Johnston
Drug Pricing Will Be a Key Issue, Whether Clinton or Trump Win the Election
By Tom Sullivan

For details on how to advertise in MM&M Weekly Digest, please email Doreen Gates

To unsubscribe from the MM&M Weekly Digest click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
275 7th Avenue, 10th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150

© 2016 Haymarket Media Inc.